Sponsors (17)
This is not an official government website.
Copyright © 2026 PLEJ LC. All rights reserved.
Amends the Public Health Service Act to promote continued availability and effectiveness of antimicrobial medicines by encouraging research and access to new antimicrobials, supporting appropriate use and high standards of medical care, and strengthening national health preparedness including protection for the military. The text is high-level and adds new material to Title III without specifying programs, funding, or operational details.
The bill seeks to improve antimicrobial development, stewardship, and preparedness—benefiting patient outcomes and national readiness—while increasing public spending, imposing compliance burdens, and potentially constraining prescribing flexibility and civilian public-health resources.
General public, patients (including older adults and immunocompromised people), and healthcare providers will gain more and better antimicrobials and preserve their effectiveness, expanding treatment options and reducing the risk of untreatable infections.
Public-health systems and military forces will be better prepared for outbreaks of resistant organisms, reducing outbreak size/impact and supporting force readiness.
Patients and clinicians will see maintained or raised standards of antimicrobial care across healthcare settings, improving overall treatment quality.
Taxpayers may face higher federal spending or incentives to boost antimicrobial R&D and market access, increasing fiscal costs.
Patients and providers could face limits on prescribing flexibility due to policies enforcing appropriate use, potentially delaying access for some individuals.
Hospitals and clinics may incur new administrative and compliance costs to meet strengthened standards and preparedness requirements.
Introduced February 4, 2026 by Buddy Carter · Last progress February 4, 2026